Mapping lymph nodes with dye for vulvar cancer
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a dye called ICG to find the first lymph nodes that might have cancer cells. It is for women with early-stage vulvar cancer that has not spread to the lymph nodes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have early-stage squamous cell carcinoma of the vulva with a tumor smaller than 4 cm.
- The tumor is at least 1 mm deep into the skin.
- The tumor is not near the urethra or anus and does not involve the lymph nodes in the groin.
- You do not have any enlarged or suspicious lymph nodes on physical exam or imaging.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to find and remove the first lymph node that might contain cancer cells in women with large or recurrent vulvar cancer. It uses a special dye to guide the surgeon, which may help improve staging and reduce side effects.
This study compares two methods for finding the first lymph node (sentinel node) that may contain cancer in people with vulvar cancer. It uses a dye called indocyanine green alone or with a radioactive tracer (technetium) to see which approach works better for staging the disease.
This trial tests if an injection of indocyanine green dye can help surgeons find and remove only the key lymph nodes in the armpit during breast cancer surgery. It aims to reduce the need for more extensive lymph node removal.
This trial tests using a green dye called ICG (indocyanine green) during breast cancer surgery to find the first lymph nodes (sentinel nodes) that cancer may have spread to. It aims to help doctors locate these nodes more accurately, and is for people with early-stage breast cancer that has not yet spread to the lymph nodes.
This trial tests a new optical method using a dye to find and remove the first lymph node (sentinel node) that cancer might spread to, to stage vulvar cancer more accurately. It's for patients with a smaller tumor (under 4 cm) that hasn't been treated in the groin area before.
This trial tests if a special dye (indocyanine green) can find the first lymph nodes (sentinel nodes) during mastectomy. It may help improve staging for women with early breast cancer who need or choose mastectomy.
Hear when a new Vulva Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.